A. annua was analyzed by GC and GC/MS and sixty-two components -myrcene (37.71%), 1, 
Introduction
Artemisia annua of China, where it has been used in the treatment of fever and malaria for many centuries. Many secondary metabolites of terpene peroxides were isolated from the plant, such as artemisia ketone, artemisinic alcohol, arteannuin B and myrcene hydroperoxide (1, 2). The most famous terpene peroxide is artemisinin with a chemical structure of amorphane-type sesquiterpene endoperoxide, and it has become an important plant-derived compound in the treatment of the chloroquineresistant and cerebral malarias (3). The essential oils, another important composition of A. annua, have been subjected to extensive phytochemicals and pharmacological activity studies. The percentage of artemisia ketone, 1, 8-cineole, camphor, borneol, germacrene D and -pinene was reported to vary from 0.0-80.9%, 0-31.5%, 0-27.5%, 0-20.0%, 0-18.9% and 0-16.0%, respectively. Other major reported components were artemisia alcohol, -pinene, carvacrol, thymol, myrcene, limonene, camphene, copaene, -caryophyllene, -terpineol, -elemene, -elemene and -elemene, sabinene, -guaiene, caryophyllene, caryophyllene oxide, and so on. The biological activities reported for the compounds isolated from A. annua essential oils, converting enzyme inhibitory, plant growth regulatory, cytokinin-like and antitumor (4).
Alzheimer is a progressive degenerative neurologic disorder resulting in impaired memory and behavior. Epidemiological data indicate a potentially considerable increase in the prevalence of the disease over the next two decades (5). Most treatment strategies have been based on the cholinergic hypothesis which postulated that memory impairments in patients of cholinergic function in brain. One of the most promising approaches for treating this disease is to enhance the acetylcholine level in the brain by means of using acetylcholinesterase (AChE) inhibitors (6). Several AChE inhibitors are being investigated for the treatment of Alzheimer. However, only tacrine, donepezil, rivastigmine, and galanthamine have been approved by the Food and Drug Administration in the United States (7). These compounds have been reported to have adverse effects including gastrointestinal disturbances and problems associated with bioavailability (8), which reinforces the interest resources.
In this study, our focus was on evaluating acetylcholinesterase inhibitory properties of A. annua phases, as there are no reports on AChE inhibitory activity of A. annua. We also determined the chemical composition of the essential oils by capillary gas chromatography coupled to mass spectrometry (GC-MS). 
Experimental

Plant materials
Essential oil extraction
The essential oils from three samples were obtained by hydrodistillation during 6 h using a Clevenger-type apparatus (9). The yield of each essential oil was determined on average over the three replicates. These oils were dried over analysis.
Microplate assay for AChE activity
The AChE inhibitory activity of esstial oils was screened by Ellman's colorimetric method -1 oscillation mixing, 37 º C pre-incubation 10 min, -1 substrate, 37 º C SDS to terminate reaction. The absorbance was measured with microplate reader at 405 nm when the reaction reached the equilibrium. A control reaction was carried out using water instead of extract. The obtained absorbance value was considered 100% activity. Inhibition (%) was calculated in the following way:
Where Asample is the absorbance of the reaction containing the extract and Acontrol is l the absorbance of the reaction control. Tests were carried out in triplicate and a blank with phosphate buffer (PB) instead of enzyme solution was done. Extract concentration providing 50% inhibition (IC 50 ) was obtained plotting the inhibition percentage against extract solution concentrations.
Analysis of the essential oils GC analysations were performed using a Shimadzu GC-2010 gas chromatograph equipped with an FID and an HP-5 fused silica column with a 5% phenyl-substituted methylpolysiloxane phase. The oven temperature was programmed The carrier gas, helium (99.999%), was adjusted to a linear velocity of 43 cm/sec. The essential diluted solution was injected into the GC/MS in the split mode with a split ratio of 1/20.
MS analyses were performed using a Shimadzu MS-QP2010 with ionization energy of 70 eV, a scan time of 0.5 s and a mass range of 33-450 amu (Atomic mass unit/Dalton (u/Da)).
comparison of their mass spectra with those of the spectrometer database using the NIST147 mass spectral database and also with those of authentic through comparing the fragmentation patterns and Retention index with those reported in the literature (12-14). The percentages of compounds were calculated by the area normalization method without considering response factors to establish abundances. The retention index was found with a standard mixture of C8 to C22 compounds under chromatography conditions, consistent with those of the chromatography conditions of the analyzed samples. For each essential oil, the RI and the peak area percentages were calculated as mean values of the three injections. ). Analysis of the results shows that these oils are moderate AChE inhibitors. Galantamine, a compound used pharmacologically, showed an IC 50 In previous reports, it has been mentioned that 1,8-cineole, camphor, -pinene, -pinene, borneol, linalool, bornyl acetate, linalyl acetate, menthone, carvone, anetole, anisole, eugenol, 
Results and Discussion
Extraction yields
